{"name":"Boston Pharmaceuticals","slug":"boston-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BOS172722","genericName":"BOS172722","slug":"bos172722","indication":"Other","status":"phase_1"},{"name":"Efimosfermin","genericName":"Efimosfermin","slug":"efimosfermin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BOS172722","genericName":"BOS172722","slug":"bos172722","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Efimosfermin","genericName":"Efimosfermin","slug":"efimosfermin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPc1RDNVZuVjNySWxqV1JBXzl5Vy03ZHoxNjlmemQxY0ZBMFNvU1E2V0N0aHppNHZuSjFOaGxwYXhManRaMnJ4bDZ4MlhRaEhpMWhkZE5ySVI4WW1oZHh4ZXY2dEJ3eVpRVTlsOU9Sc05WdzFLV1dJY01DRzlzXzh6NkxkOEloUEdnQ2MtR2pDc3g0Q2g4OU5NWVJ6cUZJXzdBWkow?oc=5","date":"2026-03-31","type":"pipeline","source":"The Business Journals","summary":"Pharma giant snags Boston-area biotech for $6.3B amid sleep medicine push - The Business Journals","headline":"Pharma giant snags Boston-area biotech for $6.3B amid sleep medicine push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNNl80cGJzb2dwT3N5UTBFekVsMXYyTjBIYW5TU2lNQV9lTThoUHFRaWhsX3VtaEp0WFNWdDU2c3RKUXI5NWpUaDAtcVZlZFRLUWNyRWdxOWdxbnl3bFd3Z0NvejB3bmo3VXQ1Q0lmLUt6NGl0aFo2MDVVcXp0MnlMYURWRnlzYzVqODgyVWcwVXJIa0hsZzExbll3dUk0eTRyQVNlVDNwUQ?oc=5","date":"2026-03-11","type":"pipeline","source":"The Business Journals","summary":"British veterinary pharma relocates global HQ to Boston - The Business Journals","headline":"British veterinary pharma relocates global HQ to Boston","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT1V5aHhnVHZMcnlfZi1mWTFjX3l5WERRUzlibG51NGNvdmVmaExNUTVSV2l2MDdvZlJtaGpxa0R3WW5JODVkbk5jdExZcldNUUE5cC1JNXFQQlViM2k0TkdsSExTbjlpaDk3cnlUMjRrWFRuSHMxMlJRZXluYUVNZnlEcGhBeFNtNDRtUGttZWJfc29VNnBiU2MzaDZxdGRuZ3VEaXJHdHN3SGczd1Jva1F2Rnh0Tm5xV3hCcnV3RERZUQ?oc=5","date":"2026-02-27","type":"pipeline","source":"boston.com","summary":"Two Boston startups join the race to create the next major weight-loss drug - boston.com","headline":"Two Boston startups join the race to create the next major weight-loss drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNRGkzWTJFZ1hpNWNVLWRsQzZVUzl1ekdtTzhUX01IRGVmaGhVS0dYY1NKRXZTTm1tTm41ajQ1NGVRMHljZ0JWVkxvNXpZdEpfTDk4RnZLd28xXzdmTU9ieXl6WTkyNGF5RndhbV9PaVg0WlFWdkNNelppLThMRUV6WmhaOENJX0VrMENKS2Z5dUVLdjdaN1JzMmUwWDdKaldURWhES0haUUZUcW5weGc?oc=5","date":"2026-02-13","type":"deal","source":"The Real Deal","summary":"Pharma Giant Puts 450K SF on Sublease Market in Cambridge - The Real Deal","headline":"Pharma Giant Puts 450K SF on Sublease Market in Cambridge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBvZWtaR0VSZmp5UWJYZ3hKR1B6ZTVaTmExNWZfT0R3U3luR2xyRDgtaHYyRlJ3cUpLVW5wT2VSYm1aVnZlU1ZVM3BxM013Si1JMTZWalFYdC1CaHpfUUhHRTltblVRWEFoZHZFMjB2M1oyZw?oc=5","date":"2026-02-11","type":"pipeline","source":"BioSpace","summary":"9 Companies Hiring in Boston - BioSpace","headline":"9 Companies Hiring in Boston","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPejFlMkc4LWxmM0FJRnRHbkFXZkJBSnk4eEp6TElzbUtwUFIzNHlTSE1TelItMTdNazEzNl9YUkhXN0M2RkNrcXdpTjI4NEdEOWhiNE5QU2pFU0Q3c0tBSHJ3ZFNsdjdUUGExZEFLdVNLMDFSRUZOWGJYeHFMRTcyX3Z5YjJlMUdmV3hBYkhJZWJBNFNOU1VF?oc=5","date":"2026-02-11","type":"pipeline","source":"Fierce Biotech","summary":"Takeda downsizes Boston footprint amid consolidation effort - Fierce Biotech","headline":"Takeda downsizes Boston footprint amid consolidation effort","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNaXpuV3hmNUFDY0Utbnl5dVM3MnZSSHItcGdtdGhDMkhiR1JZc0YtOUpoNGRQenF5Q2pVd0JWbDJza25pODhnWTdYRnc3Z05kMS1hRk5KeWtWT0thRlA0QXhtd1p5QnF4a3hzSDAteUtzeXVBTEdyajRENWViV25NUlRWby1YYXg0a0FTT0FBcG5yaGpzbE5BZkh0R3RtSDlMbzYtVDVfWVJPdWdTZmfSAbYBQVVfeXFMT3k5NkFiZllUeVg1c21Makg3UXgxRVdGSkhtWVFuOFZZT2k0Y2ZKYXpDNzhyWHZaeHpRbXZ0SVNxbjZIeEg5S1BkQ2NCV3VjU1plaTFaY2cwSzNyaHM2WWRSMzhMSFdwRjdEdXVoZUpKRUw3dm5NVHFUcEliVGNYZ3JSS0JPSnUyazloV180WFdvaXRHa1Q3ZHQ3VlZKTUxOVGJQY1Qzd3Ytd2ZYTU11QnNpWEx1Z2c?oc=5","date":"2026-01-22","type":"pipeline","source":"NBC Boston","summary":"Pharma giant triples its lease at new Harvard site - NBC Boston","headline":"Pharma giant triples its lease at new Harvard site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNSWQ4M25FSktjdHJ2WldWTHZEZVFsb1FIQ3ZoYjh6S2J5czVkWUxzNmczS21IdmhPQjlRU0ttaXVzVGZoZWJTYnZhVWVXMEpzVU9WU1BRZzFDdnBFdkZDczNfbHR6UXNxZFhOX2lmaEVnNHVLZEhyWGNES255ZmFBVkpnYjRObjV6aHA0SnhhSFdYQQ?oc=5","date":"2026-01-13","type":"pipeline","source":"Pharma Voice","summary":"3 positive trends for Massachusetts’ biopharma sector - Pharma Voice","headline":"3 positive trends for Massachusetts’ biopharma sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1WQWVKSGRjX1A1eG1yeklaNEpnaU9wamFFa1h0YmlRMEV6YkpUT2FMNkVIWW1ieF9OcndpZGFLbDJyWERoSmZJeks3VC1nNGlmOU5IRFRBVTZiN2tMREVEbXp1eDhrM1E5MHdIZV9IQ0g?oc=5","date":"2025-11-11","type":"pipeline","source":"Labiotech.eu","summary":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025 - Labiotech.eu","headline":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPZkRUQUdSVWVSR3NSRTE1ZGk3NmpMRXlTUi1IaU1RQ2xTY3lQN0U5MTd2bnVub0Z4cFk1R3ZkYWczWTZ6UFBwdElJcVRSNXRoYmE0U3U4bTNvYklMYmNmSktIa1lFSWZOaEpnTm1ZQU5hYnVQcDRZVk1UNTQ5YlowLUVJaURRS2g3OHV6UzNWVVM1aVJJaVEw?oc=5","date":"2025-07-08","type":"deal","source":"Pharmaceutical Technology","summary":"GSK acquires efimosfermin alfa from Boston Pharma for $2bn - Pharmaceutical Technology","headline":"GSK acquires efimosfermin alfa from Boston Pharma for $2bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeFYxWDhfa0ZpR21IZXpGUTZlRTRMWWdqOVRVendtYnp4ZURfc0VWSkJiTnpTZ2YwT1hWZDItMW5VX095RjFlMkhvSjlKLWZOcTFDUUJKRTYwWm9TWldkMkZLVkxIb3FuZnJRZXVnNXFzVkRHZ25pcnRFeXJiUkYzNGkzTzFMc0xsdzZJX0RYZlpQTUtsdmxIZlR0TmdjVzdjYl9pdGVDSTgtX18wdkF0NGJXc0x3eEhudS1ITlJxUFM?oc=5","date":"2025-05-14","type":"deal","source":"WSJ","summary":"GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion - WSJ","headline":"GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNMEJwYmU3ZzJUOXZ5Yjg5VFBBQm90bzZLUzFaSGNfTmMxNVppeDVvakNvZ2pRX0pxbFVwcjNCWTI5clBLZS01SW94UzN6WUNKLW1qWUlFSVJ6RmFKYTQtZTV2bmg2U1hEVGxZYkkzaUJaSF9RbmFTSWJKR1dRSGtqdUwyQUplVTA?oc=5","date":"2025-05-14","type":"deal","source":"BioPharma Dive","summary":"GSK to buy liver disease drug for $1.2B - BioPharma Dive","headline":"GSK to buy liver disease drug for $1.2B","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}